Section one: Contracting authority
one.1) Name and addresses
Genomics England
Dawson Hall, Charterhouse Square
London
EC1M 6BQ
Contact
Paul Nicholson
paul.nicholson@genomicsengland.co.uk
Telephone
+44 2078825030
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://genomicsengland.bravosolution.co.uk
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://genomicsengland.bravosolution.co.uk
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Other activity
Heath Technology
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Whole Genome Sequencing (WGS) Long Read Instruments & Consumables
Reference number
GEL-SR-291-21
two.1.2) Main CPV code
- 33696500 - Laboratory reagents
two.1.3) Type of contract
Supplies
two.1.4) Short description
The supply of instruments and consumables that provides a solution to enable investigations into methylation (5mC,5hmC), structural variant calling, copy number variant analysis and single nucleotide polymorphisms (SNP) detection, using native DNA sequencing for up to 3000 Diversity participant samples and 1000 Cancer participant samples.
two.1.5) Estimated total value
Value excluding VAT: £4,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 33140000 - Medical consumables
- 33190000 - Miscellaneous medical devices and products
- 33696200 - Blood-testing reagents
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Hinxton, Cambridge
two.2.4) Description of the procurement
Genomics England (GEL) wants to explore long-read and methylation sequencing in cancer within the NHS and accurately to sequence genomes of under-represented and diverse ancestries with a view that this novel technology could open opportunities to identify not only known genomic features and aberrations but also those that are currently unidentifiable using existing sequencing technologies. This could facilitate immediate returns in diagnostic value to the NHS and reaping more meaningful rewards in the near future through more thorough analysis of the whole genome.
Long-read analytical methods are still in their infancy, GEL is building a knowledge hub around the trusted research environment for individuals to train their methods; in turn these methods feed into the clinical pipeline of the future. Nurturing the research environment will permit the discovery of new diagnostic and prognostic markers as well as potential new targets for drug discovery to benefit patients in the future.
GEL has a requirement to purchase Long Read sequencing technology to fulfil its needs in relation to the Cancer and Diversity Programmes.
The requirement is to provide sufficient sequencing instruments and necessary consumables and kit to meet the current and forecasted need at GEL's Hinxton Lab and at 3 GLH sites for FY 22/23. The requirement also includes appropriate support & maintenance and licenses required for operation.
The anticipated forecast is set at 3000 Diversity participant samples and 1000 Cancer participant samples in this period.
There will be an optional requirement within the contract to provide sufficient instruments and consumables for up to a further 1000 Diversity participants and 500 Cancer participants to meet additional unplanned demand. There is no guarantee or warranty that the optional requirements will be purchased and tender responses relating to such optional requirements will not be evaluated.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £4,000,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 April 2022
End date
31 March 2023
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
7 March 2022
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
7 March 2022
Local time
12:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.2) Information about electronic workflows
Electronic ordering will be used
Electronic payment will be used
six.4) Procedures for review
six.4.1) Review body
The High Court
Strand
London
WC2A 2LL
Country
United Kingdom